Fostriecin, an antitumor antibiotic with inhibitory activity against serine/threonine protein phosphatases types 1 (PP1) and 2A (PP2A), is highly selective for PP2A

被引：191

作者：

Walsh, AH ^{[1
]}

Cheng, AY ^{[1
]}

Honkanen, RE ^{[1
]}

机构：

[1] UNIV S ALABAMA, COLL MED, DEPT BIOCHEM & MOL BIOL, MOBILE, AL 36688 USA

来源：

FEBS LETTERS | 1997年 / 416卷 / 03期

关键词：

fostriecin; okadaic acid; cantharidin; serine/threonine; protein; phosphatase; inhibitor; dephosphorylation; toxin; tumor promotion; antitumor activity;

D O I：

10.1016/S0014-5793(97)01210-6

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Fostriecin, an antitumor antibiotic produced by Streptomyces pulveraceus, is a strong inhibitor of type 2A (PP2A; IC50 3.2 nM) and a weak inhibitor of type 1 (PP1; IC50 131 mu M) serine/threonine protein phosphatases. Fostriecin has no apparent effect on the activity of PP2B, and dose-inhibition studies conducted with whole cell homogenates indicate that fostriecin also inhibits the native forms of PP1 and PP2A, Studies with recombinant PP1/PP2A chimeras indicate that okadaic acid and fostriecin have different binding sites. (C) 1997 Federation of European Biochemical Societies.

引用

页码：230 / 234

页数：5

共 46 条

[11] OKADAIC ACID - A NEW PROBE FOR THE STUDY OF CELLULAR-REGULATION [J].

COHEN, P ;

HOLMES, CFB ;

TSUKITANI, Y .

TRENDS IN BIOCHEMICAL SCIENCES, 1990, 15 (03) :98-102

[12]

CRITZ SD, 1995, NEUROPROTOCOLS, V6, P78

[13] Fostriecin: A review of the preclinical data [J].

deJong, RS ;

deVries, EGE ;

Mulder, NH .

ANTI-CANCER DRUGS, 1997, 8 (05) :413-418

[14] STUDIES ON THE BIOCHEMICAL-MECHANISM OF THE NOVEL ANTITUMOR AGENT, CI-920 [J].

FRY, DW ;

BORITZKI, TJ ;

JACKSON, RC .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1984, 13 (03) :171-175

[15]

FRY DW, 1984, CANCER RES, V44, P3366

[16] TUMOR PROMOTION BY INHIBITORS OF PROTEIN PHOSPHATASE-1 AND PHOSPHATASE-2A - THE OKADAIC ACID CLASS OF COMPOUNDS [J].

FUJIKI, H ;

SUGANUMA, M .

ADVANCES IN CANCER RESEARCH, VOL 61, 1993, 61 :143-194

[17] 3-DIMENSIONAL STRUCTURE OF THE CATALYTIC SUBUNIT OF PROTEIN SERINE/THREONINE PHOSPHATASE-1 [J].

GOLDBERG, J ;

HUANG, HB ;

KWON, YG ;

GREENGARD, P ;

NAIRN, AC ;

KURIYAN, J .

NATURE, 1995, 376 (6543) :745-753

[18] CHROMOSOME CONDENSATION INDUCED BY FOSTRIECIN DOES NOT REQUIRE P34(CDC2) KINASE-ACTIVITY AND HISTONE H1 HYPERPHOSPHORYLATION, BUT IS ASSOCIATED WITH ENHANCED HISTONE H2A AND H3 PHOSPHORYLATION [J].

GUO, XW ;

THNG, JPH ;

SWANK, RA ;

ANDERSON, HJ ;

TUDAN, C ;

BRADBURY, EM ;

ROBERGE, M .

EMBO JOURNAL, 1995, 14 (05) :976-985

[19] The antitumor drug fostriecin induces vimentin hyperphosphorylation and intermediate filament reorganization [J].

Ho, DT ;

Roberge, M .

CARCINOGENESIS, 1996, 17 (05) :967-972

[20] CHARACTERIZATION OF NATURAL TOXINS WITH INHIBITORY ACTIVITY AGAINST SERINE THREONINE PROTEIN PHOSPHATASES [J].

HONKANAN, RE ;

CODISPOTI, BA ;

TSE, K ;

BOYNTON, AL .

TOXICON, 1994, 32 (03) :339-350

← 1 2 3 4 5 →